Every material Form 8-K Versigent has filed with the SEC since March 24, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Versigent reported third-quarter 2026 net sales of $2.45 billion, up 7.2% year over year, but net income attributable to Versigent fell to $102 million from $109 million and diluted EPS fell to $1.41 from $1.54. The company raised the midpoint of its full-year net sales guidance and raised the upper end and midpoint of its free cash flow guidance, while tightening those ranges and its Adjusted EBITDA range.
Q3 2026 net sales of $2,450 million, up 7.2% year over year; Adjusted Net Sales Growth of approximately 1%
Diluted EPS of $1.41 vs. $1.54 a year earlier; Adjusted Diluted EPS of $1.91 vs. $1.81
Full-year 2026 net sales guidance narrowed to $9,500-$9,600 million from $9,400-$9,600 million; free cash flow guidance raised to $275-$325 million from $200-$300 million
Board declared a quarterly cash dividend of $0.13 per share, payable December 17, 2026
Versigent reported second-quarter 2026 net sales of $2.44 billion, up 10.8% from a year earlier, and net income attributable to Versigent of $118 million, up 10.3%. The company raised its full-year 2026 net sales guidance to $9.4 billion to $9.6 billion from $9.1 billion to $9.4 billion, reaffirmed its adjusted EBITDA and free cash flow guidance, and declared an inaugural quarterly dividend of $0.13 per share.
Diluted EPS was $1.64 versus $1.51 a year earlier; adjusted diluted EPS was $1.92 versus $1.89.
Adjusted EBITDA rose 24.8% to $272 million, with a margin of 11.1% versus 9.9%.
Interest expense rose to $36 million from $1 million, mainly due to senior notes and a credit facility issued in the first quarter of 2026.
The $0.13 dividend is payable September 18, 2026 to shareholders of record on September 4, 2026.
Versigent PLC, which was spun off from Aptiv PLC on April 1, 2026, reported first-quarter 2026 revenue of $2.2 billion, up 9%, but net income attributable to the company fell to $78 million from $95 million a year earlier. The company reaffirmed its full-year 2026 guidance and disclosed a dividend policy of $0.13 per share quarterly and a $250 million share repurchase program.
Revenue of $2,212 million, up from $2,024 million; up about 3% excluding currency and commodity movements
Net income attributable to Versigent of $78 million, versus $95 million; adjusted EBITDA of $203 million, versus $198 million, with margin of 9.2% versus 9.8%
Free cash flow of $(30) million, versus $3 million a year earlier, including $26 million of separation costs
Board approved a dividend policy of $0.13 per share quarterly (initial dividend not yet declared) and a $250 million share repurchase program with no expiration date; full-year 2026 guidance reaffirmed, including U.S. GAAP net income of $31
Aptiv PLC completed the spin-off of Versigent on April 1, 2026, distributing all Versigent ordinary shares to Aptiv shareholders, and Versigent began trading on the NYSE as VGNT that day. The company took on $1.35 billion in senior secured credit facilities and $1.6 billion in senior unsecured notes, with proceeds used to pay a dividend to Aptiv, and it appointed a new CEO and CFO effective with the spin-off.
Aptiv shareholders of record on March 17, 2026 received one Versigent ordinary share for every three Aptiv shares held.
Credit agreement includes a $500 million five-year term loan A, fully drawn March 27, 2026, and an $850 million five-year revolving credit facility.
Cyprium Corporation and Cyprium Holdings Luxembourg issued $800 million of 6.125% notes due 2031 and $800 million of 6.375% notes due 2034 on March 18, 2026.
Joseph T. Liotine was appointed Chief Executive Officer and Douglas R. Ostermann Chief Financial Officer, effective with the spin-off; Paul Meister became non-executive Chair.
Versigent's board appointed Paul Meister as a director, effective March 27, 2026, expanding the board from two to three members. The filing says he is expected to become board chair when the Aptiv spin-off takes effect on April 1, 2026, and the company will be renamed Versigent PLC at that point.
Board appointed Paul Meister on March 23, 2026; effective 9:00 a.m. Eastern Time on March 27, 2026
Board size increases from two to three directors; Meister joins the Audit, Compensation and Human Resources, and Nominating and Governance committees
Meister is expected to be appointed non-executive Chair; he is set to receive $300,000 in annual director pay plus a $185,000 annual Chair retainer
Meister must hold $600,000 in company ordinary shares within five years of appointment
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Versigent filing is on SEC EDGAR ↗. 8-K briefs of other companies →